AstraZeneca Revenue 2010-2024 | AZN

AstraZeneca revenue for the twelve months ending September 30, 2024 was $51.206B, a 13.8% increase year-over-year.

  • AstraZeneca annual revenue for 2023 was $45.811B, a 3.29% increase from 2022.
  • AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021.
  • AstraZeneca annual revenue for 2021 was $37.417B, a 40.58% increase from 2020.

AstraZeneca Revenue 2010-2024 | AZN

  • AstraZeneca annual revenue for 2023 was $45.811B, a 3.29% increase from 2022.
  • AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021.
  • AstraZeneca annual revenue for 2021 was $37.417B, a 40.58% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B